2022
DOI: 10.1186/s12905-022-01678-1
|View full text |Cite
|
Sign up to set email alerts
|

A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS)

Abstract: Background Despite high co-morbidity between premenstrual dysphoric disorder and mood disorders, there is a gap of research-based tools to monitor concurrent premenstrual and mood symptoms. In this study, we developed a new DSM-5-based questionnaire to prospectively monitor concurrent premenstrual and mood symptoms. Methods Fifty-two females with bipolar or major depressive disorder, ages 16–45, were enrolled in the study. Participants completed t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…An example is the McMaster Premenstrual and Mood Symptom Scale, developed by researchers at McMaster University, which is a rating form that assesses PMDD symptoms and the severity of depression and mania symptoms daily. 9 If prospective symptom ratings indicate the presence of an untreated or partially treated underlying disorder, the treatment of the underlying disorder should be tackled first. Ideally, symptom ratings for PMDD would be repeated once a woman achieved maximal symptom control of her underlying disorder with treatment.…”
mentioning
confidence: 99%
“…An example is the McMaster Premenstrual and Mood Symptom Scale, developed by researchers at McMaster University, which is a rating form that assesses PMDD symptoms and the severity of depression and mania symptoms daily. 9 If prospective symptom ratings indicate the presence of an untreated or partially treated underlying disorder, the treatment of the underlying disorder should be tackled first. Ideally, symptom ratings for PMDD would be repeated once a woman achieved maximal symptom control of her underlying disorder with treatment.…”
mentioning
confidence: 99%